triazoles has been researched along with Hepatitis B in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, J; Liu, B; Liu, Y; Lu, J; Ma, H; Peng, Y; Qiao, Y; Song, C; Wang, J; Wu, J; Yu, W | 1 |
| Siegel, MO | 1 |
| Berg, T; Brandmaier, P; Jonas, S; Lübbert, C; Mohr, FW; Pfeiffer, D; Rodloff, A; Schmelzle, M; Schubert, S; Wiltberger, G | 1 |
| Asmuth, DM; Bansal, M; Fätkenheuer, G; Heera, J; Pialoux, G; Pineda, JA; Plonski, F; Rockstroh, JK; Small, CB; Wang, R; Zhang-Roper, R | 1 |
| Chawla, PS; Kochar, MS | 1 |
| Bellos, N; Cooper, DA; Dunne, MW; Fätkenheuer, G; Felstead, S; Hirschel, B; Hoepelman, AI; Konourina, I; Lampiris, H; Lazzarin, A; Mayer, H; Nelson, M; Raffi, F; Ridgway, C; Saag, M; Sullivan, JF; Tawadrous, M; Tebas, P; Trottier, B; van der Ryst, E; Westby, M | 1 |
| Dufty, NE; Else, LJ; Gilleran, G; Hawkins, D; Taylor, S | 1 |
1 review(s) available for triazoles and Hepatitis B
| Article | Year |
|---|---|
What's new in clinical pharmacology and therapeutics.
Topics: Abatacept; Acetanilides; Amides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiparkinson Agents; Antirheumatic Agents; Antiviral Agents; Apomorphine; Benzazepines; Cardiovascular Agents; Fumarates; Hepatitis B; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Hypoglycemic Agents; Immunoconjugates; Multiple Sclerosis; Natalizumab; Nucleosides; Papillomavirus Vaccines; Pharmacology, Clinical; Piperazines; Pyrazines; Pyrimidinones; Quinoxalines; Ranolazine; Sitagliptin Phosphate; Smoking Cessation; Telbivudine; Thymidine; Triazoles; Varenicline; Viral Vaccines | 2008 |
1 trial(s) available for triazoles and Hepatitis B
| Article | Year |
|---|---|
Hepatic safety of maraviroc in patients with HIV-1 and hepatitis C and/or B virus: 144-week results from a randomized, placebo-controlled trial.
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Coinfection; Cyclohexanes; Female; Hepatitis B; Hepatitis C; HIV Fusion Inhibitors; HIV Infections; Humans; Liver; Liver Function Tests; Male; Maraviroc; Middle Aged; Treatment Outcome; Triazoles; Viral Load | 2017 |
5 other study(ies) available for triazoles and Hepatitis B
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
Topics: Animals; Antiviral Agents; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Ducks; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatitis B Virus, Duck; Humans; Models, Molecular; Molecular Structure; Monosaccharides; Nucleosides; Structure-Activity Relationship; Triazoles; Virus Replication | 2018 |
Reactivation of hepatitis B virus infection associated with maraviroc use in an HIV-infected patient.
Topics: Aged; Anti-HIV Agents; Cyclohexanes; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Male; Maraviroc; Triazoles; Virus Activation | 2014 |
Invasive cardiac aspergillosis after orthotopic liver transplantation.
Topics: Acute Disease; Caspofungin; Drug Therapy, Combination; Echinocandins; Echocardiography, Transesophageal; Hepatitis B; Humans; Lipopeptides; Liver Failure; Liver Transplantation; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Opportunistic Infections; Postoperative Complications; Pulmonary Aspergillosis; Triazoles | 2014 |
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.
Topics: Adult; Aged; Anti-Retroviral Agents; CCR5 Receptor Antagonists; CD4 Lymphocyte Count; Cyclohexanes; Double-Blind Method; Drug Therapy, Combination; Enfuvirtide; Ethnicity; Female; Genotype; Hepatitis B; Hepatitis C; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Male; Maraviroc; Middle Aged; Odds Ratio; Peptide Fragments; Receptors, CCR5; RNA, Viral; Transaminases; Treatment Outcome; Triazoles; Viral Load | 2008 |
Pharmacokinetic interaction of maraviroc with tacrolimus in a patient coinfected with HIV and hepatitis B virus following hepatic transplant due to hepatocellular carcinoma.
Topics: Anti-HIV Agents; Carcinoma, Hepatocellular; Cyclohexanes; Drug Interactions; Hepatitis B; HIV Infections; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Maraviroc; Middle Aged; Plasma; Tacrolimus; Treatment Outcome; Triazoles | 2013 |